Exodus Point Capital Management, LP Cidara Therapeutics, Inc. Transaction History

Exodus Point Capital Management, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$0.67 - $1.39 $7,729 - $16,036	-11,537 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$1.18 - $2.18 $110 - $204	94 Added 0.82%	11,537 $15,000
Q3 2021 Nov 15, 2021	SELL	$1.48 - $2.35 $20,836 - $33,085	-14,079 Reduced 55.16%	11,443 $26,000
Q2 2021 Aug 16, 2021	BUY	$1.87 - $2.7 $47,726 - $68,909	25,522 New	25,522 $52,000
Q2 2020 Aug 14, 2020	SELL	$2.39 - $4.0 $38,823 - $64,976	-16,244 Closed	0 $0

Q1 2020 May 15, 2020	BUY	$1.74 - $4.26 $28,264 - $69,199	16,244 New	16,244 $40,000

22.1M

2.7K

100

Ticker CDTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,075,696
Market Cap $889M
Description
Cidara Therapeutics, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of long-acting anti-infectives for the treatment and prevention of infectious diseases and oncology in the United States. The company's lead product candidate is rezafungin acetate, a novel molecule in the echinocandin class of antifu...

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Exodus Point Capital Management, LP with notifications on news.